Sometime I think we lose sight with the negatives
Post# of 148187
(Total Views: 406)
Posted On: 12/11/2019 9:15:05 PM
Sometime I think we lose sight with the negatives with share price now of just how rare drug approval is, yeah the FDA is a pain in the butt to everyone, not just us. How many small biotech every reach drug approval?
https://www.medscape.com/viewarticle/405869_4
Few Drugs Gain Approval
To put this frustration into perspective, getting a drug on to pharmacy shelves is actually rare with the ratio of researched drugs gaining FDA approval somewhere between 5,000 and 10,000-to 1 . In 2016, only 22 medicines were cleared for sale, the lowest number since 2010 and down from 45 in 2015. Most drug developments fail and those that do make it require passing an approval process that typically spans over a decade and costs nearly $3 billion.
https://www.medscape.com/viewarticle/405869_4
Few Drugs Gain Approval
To put this frustration into perspective, getting a drug on to pharmacy shelves is actually rare with the ratio of researched drugs gaining FDA approval somewhere between 5,000 and 10,000-to 1 . In 2016, only 22 medicines were cleared for sale, the lowest number since 2010 and down from 45 in 2015. Most drug developments fail and those that do make it require passing an approval process that typically spans over a decade and costs nearly $3 billion.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼